Knights Of Columbus Asset Advisors LLC Karyopharm Therapeutics Inc. Transaction History

Knights Of Columbus Asset Advisors LLC

  • $1.48 Billion
  • Q3 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 12, 2021
SELL
$8.11 - $11.11 $586,701 - $803,730
-72,343 Closed
0 $0
Q1 2021

May 17, 2021
SELL
$9.85 - $17.69 $6,087 - $10,932
-618 Reduced 0.85%
72,343 $761,000
Q4 2020

Feb 16, 2021
SELL
$14.15 - $17.19 $1,896 - $2,303
-134 Reduced 0.18%
72,961 $1.13 Million
Q3 2020

Nov 13, 2020
BUY
$14.14 - $19.71 $161,196 - $224,694
11,400 Added 18.48%
73,095 $1.07 Million
Q2 2020

Aug 14, 2020
BUY
$16.6 - $25.25 $1.02 Million - $1.56 Million
61,695 New
61,695 $1.17 Million

Others Institutions Holding KPTI

# of Institutions
97
Shares Held
57.6M
Call Options Held
258K
Put Options Held
81.2K
View Full List

About Karyopharm Therapeutics Inc.

KPTI Quotes by TradingView
  • Ticker KPTI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 79,806,600
  • Market Cap $54.3M
  • Description
  • Karyopharm Therapeutics Inc., a commercial-stage pharmaceutical company, discovers, develops, and commercializes drugs directed against nuclear export for the treatment of cancer and other diseases. The company discovers, develops, and commercializes novel and Selective Inhibitor of Nuclear Export (SINE) compounds function by binding with and in...
More about KPTI
Track This Portfolio

Track Knights Of Columbus Asset Advisors LLC Portfolio

Follow Knights Of Columbus Asset Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Knights Of Columbus Asset Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Knights Of Columbus Asset Advisors LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email